Literature DB >> 2270486

Inheritance of proliferative breast disease in breast cancer kindreds.

M H Skolnick1, L A Cannon-Albright, D E Goldgar, J H Ward, C J Marshall, G B Schumann, H Hogle, W P McWhorter, E C Wright, T D Tran.   

Abstract

Previous studies have emphasized that genetic susceptibility to breast cancer is rare and is expressed primarily as premenopausal breast cancer, bilateral breast cancer, or both. Proliferative breast disease (PBD) is a significant risk factor for the development of breast cancer and appears to be a precursor lesion. PBD and breast cancer were studied in 103 women from 20 kindreds that were selected for the presence of two first degree relatives with breast cancer and in 31 control women. Physical examination, screening mammography, and four-quadrant fine-needle breast aspirates were performed. Cytologic analysis of breast aspirates revealed PBD in 35% of clinically normal female first degree relatives of breast cancer cases and in 13% of controls. Genetic analysis suggests that genetic susceptibility causes both PBD and breast cancer in these kindreds. This study supports the hypothesis that this susceptibility is responsible for a considerable portion of breast cancer, including unilateral and postmenopausal breast cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2270486     DOI: 10.1126/science.2270486

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

Review 1.  The pathology of familial breast cancer: The pre-BRCA1/BRCA2 era: historical perspectives.

Authors:  M J van de Vijver
Journal:  Breast Cancer Res       Date:  1999-10-27       Impact factor: 6.466

Review 2.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

3.  Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease.

Authors:  P Margaritte; C Bonaiti-Pellie; M C King; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

Review 4.  Risk assessment and management of high risk familial breast cancer.

Authors:  D G R Evans; F Lalloo
Journal:  J Med Genet       Date:  2002-12       Impact factor: 6.318

5.  Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways.

Authors:  Catherine Ibarra-Drendall; Michelle M Troch; William T Barry; Gloria Broadwater; Emanuel F Petricoin; Julia Wulfkuhle; Lance A Liotta; Siya Lem; Joseph C Baker; Anne C Ford; Lee G Wilke; Carola Zalles; Nicole M Kuderer; Abigail W Hoffman; Melanie Shivraj; Priya Mehta; Jamila Williams; Nora Tolbert; Laurie W Lee; Patrick G Pilie; Dihua Yu; Victoria L Seewaldt
Journal:  Breast Cancer Res Treat       Date:  2011-06-07       Impact factor: 4.872

Review 6.  Familial breast cancer.

Authors:  D G Evans; I S Fentiman; K McPherson; D Asbury; B A Ponder; A Howell
Journal:  BMJ       Date:  1994-01-15

7.  Combined segregation and linkage analysis of Graves disease with a thyroid autoantibody diathesis.

Authors:  D C Shields; S Ratanachaiyavong; A M McGregor; A Collins; N E Morton
Journal:  Am J Hum Genet       Date:  1994-09       Impact factor: 11.025

Review 8.  Cytokine therapeutics: lessons from interferon alpha.

Authors:  J U Gutterman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

Review 9.  Clinical management of women at increased risk for breast cancer.

Authors:  V G Vogel; A Yeomans; E Higginbotham
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

10.  Chromosome 17q linkage studies of 18 Utah breast cancer kindreds.

Authors:  D E Goldgar; L A Cannon-Albright; A Oliphant; J H Ward; G Linker; J Swensen; T D Tran; P Fields; P Uharriet; M H Skolnick
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.